UnknownPhase 4

Is it Effective to Treat Patients With Blastocystis Hominis Infection?

Switzerland200 participantsStarted 2012-11

Plain-language summary

The objective of this study is to determine whether in the setting of primary health care it is effective to treat with metronidazole returning travellers with gastrointestinal symptoms and B. hominis in the stool or not.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥ 18 years * Gastrointestinal symptoms for more than 10 days * B. hominis in any quantity in at least one stool specimen out of 3 examined * No other pathogenic micro-organism identified Exclusion Criteria: * Fever \> 37.5° * bloody diarrhoea * weight loss \> 10% of usual body weight * significant decrease of general condition * oncological diseases * immune deficiencies * known chronic intestinal diseases * use of anti-protozoan drugs in the last 2 weeks * use of anti-coagulant treatment or antabuse * pregnant and lactating women

What they're measuring

Improvement of gastro-intestinal symptoms

Timeframe: 10-14 days after treatment with Metronidazol

Trial details

NCT IDNCT01521403

SponsorUniversity of Lausanne Hospitals

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12-31

View on ClinicalTrials.gov More Blastocystis Hominis Infections trials